Atlantic Central Enterprises Ltd. owns patents of trans dermal drug delivery and skin permeation technology. The firm engages in electromedical and electrotherapeutic apparatus manufacturing.
Follow-Up Questions
What is Atlantic Central Enterprises Ltd (ALCN)'s P/E Ratio?
The P/E ratio of Atlantic Central Enterprises Ltd is N/A
What is the price performance of ALCN stock?
The current price of ALCN is 0, it has decreased 0% in the last trading day.
What are the primary business themes or industries for Atlantic Central Enterprises Ltd?
Atlantic Central Enterprises Ltd belongs to N/A industry and the sector is N/A
What is Atlantic Central Enterprises Ltd market cap?
Atlantic Central Enterprises Ltd's current market cap is $0
Is Atlantic Central Enterprises Ltd a buy, sell, or hold?
According to wall street analysts, 0 analysts have made analyst ratings for Atlantic Central Enterprises Ltd, including 0 strong buy, 0 buy, 0 hold, 0 sell, and 0 strong sell
